| cilostazol / Generic mfg. |
NCT00404781: Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention |
|
|
| Completed | 4 | 305 | RoW | cilostazol in addition to aspirin and clopidogrel | Shenyang Northern Hospital | Ischemic Heart Disease, Acute Coronary Syndromes | 06/07 | 06/07 | | |
ACCEL-2C19, NCT01012193: Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism |
|
|
| Completed | 4 | 134 | RoW | cilostazol 100mg bid or clopidogrel 150-mg daily | Gyeongsang National University Hospital | Coronary Artery Disease, Percutaneous Coronary Intervention | 07/09 | 09/09 | | |
ACCEL-AMI-2C19, NCT00915733: Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism |
|
|
| Completed | 4 | 80 | RoW | cilostazol, Otsuka brand of cilostazol, clopidogrel (Plavix), Plavix, CYP2C19, Cytochrome 2C19, aspirin (Acetylsalicylic acid), Acetylsalicylic acid | Gyeongsang National University Hospital | Myocardial Infarction | 10/09 | 11/09 | | |
| Completed | 4 | 486 | RoW | cilostazol, placebo | CardioVascular Research Foundation, Korea, Otsuka Korea | Coronary Artery Disease | 12/09 | 02/10 | | |
| Completed | 4 | 960 | RoW | cilostazol, Pletaal (Otsuka pharmaceutical) | Seoul National University Hospital | Coronary Artery Disease | 01/10 | 01/10 | | |
PIANO-CKD2, NCT01328470: Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease |
|
|
| Completed | 4 | 85 | RoW | Clopidogrel, cilostazol, Plavix, pletaal | Kyunghee University Medical Center | Chronic Kidney Disease, Stable Angina | 08/10 | 08/10 | | |
NCT01094457: Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation |
|
|
| Completed | 4 | 840 | RoW | aspirin, clopidogrel, aspirin, clopidogrel, cilostazol | Shenyang Northern Hospital | Acute Coronary Syndromes, Percutaneous Coronary Intervention, Clopidogrel Low Responsiveness | 04/12 | 06/12 | | |
| Completed | 4 | 220 | RoW | Dual Anti-Platelet Therapy (DAPT), Triple Anti-Platelet Therapy (TAPT) | Gyeongsang National University Hospital | Platelet Aggregation Inhibitors, Anti-inflammatory Agent, Myocardial Reperfusion Injury | 07/12 | | | |
ABCD, NCT01192724: Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation |
|
|
| Completed | 4 | 630 | RoW | Cilostazol, pletaal, Aspirin, Aspirin protect, Astrix, Baby rhonal, Clopidogrel, Plavix, Plavitor, Platless | Yonsei University | Coronary Artery Disease | 12/12 | 12/12 | | |
NCT01515228: Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III) |
|
|
| Completed | 4 | 291 | RoW | Xience Prime, everolimus-eluting stent, Cilotax stent, paclitaxel with cilostazol dual drug eluting stent | CHEOL WHAN LEE, MD, PhD., CardioVascular Research Foundation, Korea | Coronary Artery Disease | 12/14 | 01/15 | | |
| Terminated | 4 | 402 | RoW | Cilostazol, Pletaal, Placebo | Seung-Jung Park, Otsuka Pharmaceutical Development & Commercialization, Inc. | Coronary Artery Disease | 02/15 | 02/15 | | |
